English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 13 Help

Selected(0)Clear Items/Page:    Sort:
Divergent electroencephalogram resting-state functional network alterations in subgroups of autism spectrum disorder: a symptom-based clustering analysis Journal article
Zhu, Gang, Li, Yuhang, Wan, Lin, Sun, Chunhua, Liu, Xinting, Zhang, Jing, Liang, Yan, Liu, Guoyin, Yan, Huimin, Li, Rihui, Yang, Guang. Divergent electroencephalogram resting-state functional network alterations in subgroups of autism spectrum disorder: a symptom-based clustering analysis[J]. Cerebral Cortex, 2024, 34(1).
Authors:  Zhu, Gang;  Li, Yuhang;  Wan, Lin;  Sun, Chunhua;  Liu, Xinting; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:2.9/3.7 | Submit date：2024/02/22
Autism Spectrum Disorder  Electroencephalogram  Functional Connectivity  Phenotype  
Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature Journal article
Xue, Yan, Zou, Huimin, Ruan, Zhen, Chen, Xianwen, Lai, Yunfeng, Yao, Dongning, Ung, Carolina Oi Lam, Hu, Hao. Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature[J]. Frontiers in Endocrinology, 2023, 14, 1254398.
Authors:  Xue, Yan;  Zou, Huimin;  Ruan, Zhen;  Chen, Xianwen;  Lai, Yunfeng; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:3.9/4.9 | Submit date：2024/02/22
Anti-obesity Drugs  Cost-effectiveness  Methodology  Modeling  Obesity  
Comparative analysis of disease modelling for health economic evaluations of systemic therapies in advanced hepatocellular carcinoma Journal article
Zou, Huimin, Xue, Yan, Chen, Xianwen, Lai, Yunfeng, Yao, Dongning, Ung, Carolina Oi Lam, Hu, Hao. Comparative analysis of disease modelling for health economic evaluations of systemic therapies in advanced hepatocellular carcinoma[J]. PLoS ONE, 2023, 18(10 October), e0292239.
Authors:  Zou, Huimin;  Xue, Yan;  Chen, Xianwen;  Lai, Yunfeng;  Yao, Dongning; et al.
Favorite | TC[WOS]:0 TC[Scopus]:1  IF:2.9/3.3 | Submit date：2023/11/01
DDX24 Is Essential for Cell Cycle Regulation in Vascular Smooth Muscle Cells During Vascular Development via Binding to FANCA mRNA Journal article
Gong, Yujiao, Liang, Yan, Liu, Jie, Wei, Jiaxing, Zhang, Shushan, Chen, Fangbin, Zhang, Qianqian, Wang, Lijie, Lan, Huimin, Wu, Lily, Ge, Wei, Li, Shuai, Wang, Li, Shan, Hong, He, Huanhuan. DDX24 Is Essential for Cell Cycle Regulation in Vascular Smooth Muscle Cells During Vascular Development via Binding to FANCA mRNA[J]. Arteriosclerosis, thrombosis, and vascular biology, 2023, 43(9), 1653-1667.
Authors:  Gong, Yujiao;  Liang, Yan;  Liu, Jie;  Wei, Jiaxing;  Zhang, Shushan; et al.
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:7.4/8.1 | Submit date：2023/09/12
Cell Cycle  Dead-box Rna Helicases  Dna Damage  Embryonic Development  Fanconi Anemia Complementation Group a Protein  
Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis Journal article
Huimin Zou, Qing Lei, Xin Yan, Yunfeng Lai, Carolina Oi Lam Ung, Hao Hu. Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis[J]. Cancers, 2022, 15(1), 260.
Authors:  Huimin Zou;  Qing Lei;  Xin Yan;  Yunfeng Lai;  Carolina Oi Lam Ung; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:4.5/4.9 | Submit date：2023/02/08
Advanced Hepatocellular Carcinoma  Clinical Outcomes  First-line  Immune Checkpoint Inhibitors  Meta-analysis  
Efficacy and Safety of First-Line Targeted Treatment and Immunotherapy for Patients with Biliary Tract Cancer: A Systematic Review and Meta-Analysis Journal article
Xin Yan, Huimin Zou, Yunfeng Lai, Carolina Oi Lam Ung, Hao Hu. Efficacy and Safety of First-Line Targeted Treatment and Immunotherapy for Patients with Biliary Tract Cancer: A Systematic Review and Meta-Analysis[J]. Cancers, 2022, 15(1), 39.
Authors:  Xin Yan;  Huimin Zou;  Yunfeng Lai;  Carolina Oi Lam Ung;  Hao Hu
Favorite | TC[WOS]:3 TC[Scopus]:2  IF:4.5/4.9 | Submit date：2023/02/08
Biliary Tract Cancer  Cholangiocarcinoma  Immunotherapy  Targeted Therapy  
Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials Journal article
Lin, Qiucen, Xue, Yan, Zou, Huimin, Ruan, Zhen, Ung, Carolina Oi Lam, Hu, Hao. Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials[J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15(12), 1461-1469.
Authors:  Lin, Qiucen;  Xue, Yan;  Zou, Huimin;  Ruan, Zhen;  Ung, Carolina Oi Lam; et al.
Favorite | TC[WOS]:11 TC[Scopus]:11  IF:3.6/4.1 | Submit date：2023/01/08
Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China Journal article
Ruan, Zhen, Ung, Carolina Oi Lam, Shen, Yang, Zhang, Yawen, Wang, Weihao, Luo, Jingyi, Zou, Huimin, Xue, Yan, Wang, Yao, Hu, Hao, Guo, Lixin. Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China[J]. DIABETES THERAPY, 2022, 13(10), 1737-1753.
Authors:  Ruan, Zhen;  Ung, Carolina Oi Lam;  Shen, Yang;  Zhang, Yawen;  Wang, Weihao; et al.
Favorite | TC[WOS]:6 TC[Scopus]:9  IF:2.8/2.9 | Submit date：2022/08/28
China  Cost-effectiveness  Diabetes  Dulaglutide  Semaglutide  
Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and network meta-analysis Review article
2022
Authors:  Lei, Qing;  Yan, Xin;  Zou, Huimin;  Jiang, Yixuan;  Lai, Yunfeng; et al.
Favorite | TC[WOS]:14 TC[Scopus]:11  IF:2.8/2.8 | Submit date：2023/01/30
First-line  Immune Checkpoint Inhibitors  Meta-analysis  Network Meta-analysis  Unresectable Hepatocellular Carcinoma  
Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and net Journal article
Lei, Qing, Yan, Xin, Zou, Huimin, Jiang, Yixuan, Lai, Yunfeng, Ung, Carolina Oi Lam, Hu, Hao. Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and net[J]. Discover Oncology, 2022.
Authors:  Lei, Qing;  Yan, Xin;  Zou, Huimin;  Jiang, Yixuan;  Lai, Yunfeng; et al.
Favorite |   IF:2.8/2.8 | Submit date：2023/01/08